Albert A. Luderer, Howard H. Weetall
Clinical Cellular Immunology (eBook, PDF)
Molecular and Therapeutic Reviews
73,95 €
73,95 €
inkl. MwSt.
Sofort per Download lieferbar
73,95 €
Als Download kaufen
73,95 €
inkl. MwSt.
Sofort per Download lieferbar
Albert A. Luderer, Howard H. Weetall
Clinical Cellular Immunology (eBook, PDF)
Molecular and Therapeutic Reviews
- Format: PDF
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
Zur Zeit liegt uns keine Inhaltsangabe vor.
- Geräte: PC
- ohne Kopierschutz
- eBook Hilfe
- Größe: 25.96MB
Zur Zeit liegt uns keine Inhaltsangabe vor.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Humana Press
- Seitenzahl: 392
- Erscheinungstermin: 6. Dezember 2012
- Englisch
- ISBN-13: 9781461258025
- Artikelnr.: 44045409
- Verlag: Humana Press
- Seitenzahl: 392
- Erscheinungstermin: 6. Dezember 2012
- Englisch
- ISBN-13: 9781461258025
- Artikelnr.: 44045409
1 The T Cell Antigen Receptor: Structural and Functional Considerations.- 1. Overview.- 2. Functional and Physical Analysis of T Cell Antigen-Specific Receptors.- 3. Serological and Biochemical Analysis of T Cell Antigen-Specific Receptors.- 4. Physiologic Constraints in the Recognition Function of the T Cell Antigen Receptor.- 5. Cytotoxic T Cell Ligand-Binding Sites are Critically Affected by Recognition Structures on Other Cells.- 6. Summary.- References.- 2 Regulation of the Immune Response.- 1. Introduction.- 2. Ir Genes in Guinea Pigs.- 3. The Ir-1 Gene.- 4. Genetic Control of Immune Responsiveness to Staphylococcal Nuclease.- 5. Ia Antigens.- 6. Complementing Ir Genes.- 7. Immunosuppressor Genes.- 8. Genetic Control of Cellular Immune Responses.- 9. Human Immune-Response Genes.- 10. An Hypothesis to Explain the Interrelationship Among Ir Genes, Ia Antigens, and MLR-Stimulating Determinants.- 11. Conclusions.- References.- 3 Immunosuppressive Agents: A Conceptual Overview of Their Action on Inductive and Regulatory Pathways.- 1. Introduction.- 2. Inductive and Regulatory Aspects of Immune Responses: Current Concepts.- 3. Classes and Subclasses of Lymphocytes and Their Functions.- 4. Antibody Responses to Thymus-Independent and Thymus-Dependent Antigens.- 5. Inductive and Regulatory Functions: Antigens, Cells, Cognitive and Regulating Molecules, and Networks.- 6. A Closer Look at Induction and Regulation of Cell-Mediated Immunity.- Acknowledgments.- References.- 4 Immunosuppressive Agents-Their Action on Inductive and Regulatory Pathways: The Differential Effects of Agents Used Clinically or Experimentally in the Treatment of Cancer.- 1. Variables that Determine the Effect of Cancer Therapeutic Agents on Antibody Production.- 2. Diversity of Effects ofImmunosuppressive Drugs on CMI.- 3. Alkylating Agents Exert Selective Action Against Cells in the Suppressor Pathway.- 4. A Closer Look at Agents That Are More Suppressive Before Immunization.- 5. The Many Faces and Interfaces of Cyclophosphamide Action.- Acknowledgments.- References.- 5 The Immunobiology of Human Non-Hodgkin's Lymphomas.- 1. Introduction.- 2. Classification Schema.- 3. Functional Studies.- 4. The Ontogeny of Lymphocytes.- 5. Overview of Immunoregulation.- 6. Lymphocyte Identification.- 7. New Directions.- Acknowledgments.- References.- 6 Cell-Mediated Immunity in Autoimmune Disease.- 1. Introduction.- 2. Self-Recognition and Tolerance.- 3. Induction of Autoimmunity.- 4. Pathogenic Mechanisms in Autoimmune Disease.- 5. Cell-Mediated Immunity in Autoimmune Diseases of Animals.- 6. Cell-Mediated Immunity in Autoimmune Disease of Humans.- 7. Summary.- References.- 7 Cell-Mediated Immunity in Tumor Rejection.- 1. Immune Surveillance-A Theory Under Scrutiny.- 2. Tumor Antigens.- 3. Effector Mechanisms in Cell-Mediated Immunity.- 4. Effector Molecules.- 5. Depression of Immunity by Tumors: Suppressor Cells and Factors.- 6. Immunotherapy.- 7. Conclusions.- References.- 8 Transfer Factor and Other Factors in Leukocyte Dialyzates That Affect Cell-Mediated Immunity.- 1. Introduction.- 2. The Transfer Phenomenon.- 3. Clinical Use of Leukocyte Dialyzates or Transfer-Factor Preparations.- 4. Biochemical Characterization.- 5. Experimental Considerations.- 6. Implications for Immunotherapy.- References.- 9 Hybridization of Lymphocytes: Techniques and Applications.- 1. Introduction.- 2. B Cell Hybrids.- 3. T Cell Hybrids.- 4. Applications and Future Perspectives.- Notes Added in Proof.- Acknowledgment.- References.- 10 Immunologic Tests for Diagnosis andMonitoring of Defects in Cell-Mediated Immunity.- 1. Introduction.- 2. Anatomy of the Immune System.- 3. In Vivo Manifestations of Cell-Mediated Immunity.- 4. In Vitro Tests of Cell-Mediated Immunity.- 5. Clinical Immunodeficiencies.- 6. Conclusion.- Acknowledgments.- References.
1 The T Cell Antigen Receptor: Structural and Functional Considerations.- 1. Overview.- 2. Functional and Physical Analysis of T Cell Antigen-Specific Receptors.- 3. Serological and Biochemical Analysis of T Cell Antigen-Specific Receptors.- 4. Physiologic Constraints in the Recognition Function of the T Cell Antigen Receptor.- 5. Cytotoxic T Cell Ligand-Binding Sites are Critically Affected by Recognition Structures on Other Cells.- 6. Summary.- References.- 2 Regulation of the Immune Response.- 1. Introduction.- 2. Ir Genes in Guinea Pigs.- 3. The Ir-1 Gene.- 4. Genetic Control of Immune Responsiveness to Staphylococcal Nuclease.- 5. Ia Antigens.- 6. Complementing Ir Genes.- 7. Immunosuppressor Genes.- 8. Genetic Control of Cellular Immune Responses.- 9. Human Immune-Response Genes.- 10. An Hypothesis to Explain the Interrelationship Among Ir Genes, Ia Antigens, and MLR-Stimulating Determinants.- 11. Conclusions.- References.- 3 Immunosuppressive Agents: A Conceptual Overview of Their Action on Inductive and Regulatory Pathways.- 1. Introduction.- 2. Inductive and Regulatory Aspects of Immune Responses: Current Concepts.- 3. Classes and Subclasses of Lymphocytes and Their Functions.- 4. Antibody Responses to Thymus-Independent and Thymus-Dependent Antigens.- 5. Inductive and Regulatory Functions: Antigens, Cells, Cognitive and Regulating Molecules, and Networks.- 6. A Closer Look at Induction and Regulation of Cell-Mediated Immunity.- Acknowledgments.- References.- 4 Immunosuppressive Agents-Their Action on Inductive and Regulatory Pathways: The Differential Effects of Agents Used Clinically or Experimentally in the Treatment of Cancer.- 1. Variables that Determine the Effect of Cancer Therapeutic Agents on Antibody Production.- 2. Diversity of Effects ofImmunosuppressive Drugs on CMI.- 3. Alkylating Agents Exert Selective Action Against Cells in the Suppressor Pathway.- 4. A Closer Look at Agents That Are More Suppressive Before Immunization.- 5. The Many Faces and Interfaces of Cyclophosphamide Action.- Acknowledgments.- References.- 5 The Immunobiology of Human Non-Hodgkin's Lymphomas.- 1. Introduction.- 2. Classification Schema.- 3. Functional Studies.- 4. The Ontogeny of Lymphocytes.- 5. Overview of Immunoregulation.- 6. Lymphocyte Identification.- 7. New Directions.- Acknowledgments.- References.- 6 Cell-Mediated Immunity in Autoimmune Disease.- 1. Introduction.- 2. Self-Recognition and Tolerance.- 3. Induction of Autoimmunity.- 4. Pathogenic Mechanisms in Autoimmune Disease.- 5. Cell-Mediated Immunity in Autoimmune Diseases of Animals.- 6. Cell-Mediated Immunity in Autoimmune Disease of Humans.- 7. Summary.- References.- 7 Cell-Mediated Immunity in Tumor Rejection.- 1. Immune Surveillance-A Theory Under Scrutiny.- 2. Tumor Antigens.- 3. Effector Mechanisms in Cell-Mediated Immunity.- 4. Effector Molecules.- 5. Depression of Immunity by Tumors: Suppressor Cells and Factors.- 6. Immunotherapy.- 7. Conclusions.- References.- 8 Transfer Factor and Other Factors in Leukocyte Dialyzates That Affect Cell-Mediated Immunity.- 1. Introduction.- 2. The Transfer Phenomenon.- 3. Clinical Use of Leukocyte Dialyzates or Transfer-Factor Preparations.- 4. Biochemical Characterization.- 5. Experimental Considerations.- 6. Implications for Immunotherapy.- References.- 9 Hybridization of Lymphocytes: Techniques and Applications.- 1. Introduction.- 2. B Cell Hybrids.- 3. T Cell Hybrids.- 4. Applications and Future Perspectives.- Notes Added in Proof.- Acknowledgment.- References.- 10 Immunologic Tests for Diagnosis andMonitoring of Defects in Cell-Mediated Immunity.- 1. Introduction.- 2. Anatomy of the Immune System.- 3. In Vivo Manifestations of Cell-Mediated Immunity.- 4. In Vitro Tests of Cell-Mediated Immunity.- 5. Clinical Immunodeficiencies.- 6. Conclusion.- Acknowledgments.- References.